Proteostasis Therapeutics, Inc.
(NASDAQ : PTI)

( )
PTI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-1.67%292.231.4%$590.52m
AMGNAmgen, Inc.
0.07%234.011.3%$503.19m
GILDGilead Sciences, Inc.
1.04%67.781.0%$366.31m
REGNRegeneron Pharmaceuticals, Inc.
1.59%373.532.6%$302.52m
VRTXVertex Pharmaceuticals, Inc.
-0.12%220.001.9%$273.01m
ILMNIllumina, Inc.
-1.95%320.573.5%$231.88m
ARWRArrowhead Pharmaceuticals, Inc.
-3.73%68.2211.4%$207.81m
CLVSClovis Oncology, Inc.
-3.14%11.7214.7%$207.81m
ALXNAlexion Pharmaceuticals, Inc.
-1.53%109.502.0%$195.03m
EXASEXACT Sciences Corp.
-0.15%85.1724.0%$163.33m
AAgilent Technologies, Inc.
0.60%83.431.6%$159.09m
GBTGlobal Blood Therapeutics, Inc.
3.29%78.456.0%$142.09m
BLUEbluebird bio, Inc.
1.49%86.9714.2%$139.80m
BOLDAudentes Therapeutics, Inc.
-0.12%59.441.4%$134.26m
SGENSeattle Genetics, Inc.
-2.32%111.346.1%$128.54m

Company Profile

Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.